Skip to content

Clinical trials

Dementia trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dementia Country / region: Czechia Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20071
20111
20132
20141
20151
20162
20171
20202
20221
20231
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated5
Recruiting4
Active, not recruiting1
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
FORUM Pharmaceuticals Inc2
Novartis Pharmaceuticals2
ACADIA Pharmaceuticals Inc.1
Affiris AG1
Axovant Sciences Ltd.1
Bristol-Myers Squibb1
Eisai Co., Ltd.1
Eli Lilly and Company1
Faculty Hospital Kralovske Vinohrady1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dementia19
Alzheimer Disease18
Cognitive Dysfunction7
Brain Diseases4
Mental Disorders4
Nervous System Diseases4
Neurodegenerative Diseases4
Tauopathies4
Central Nervous System Diseases3
Hallucinations2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.